Online event
Building strategic business networks in the China Medtech Sector
Friday 12 December at 9:00AM
Event endedDo you know what the best partnership model for your busines is when looking to access the Chinese Medtech sector? If not join our webinar to learn more about the different types.
What you’ll learn
- Discover key strategies for entering China’s healthcare market, including structuring partnerships, accessing local capital, and manufacturing partnerships.
- Learn about investment options, and regional incentives in high-growth areas like the Yangtze River Delta and Greater Bay Area, which are ideal for businesses building networks and scaling operations in China.
Description
Building strategic network is essential to succeed in a country with a different culture and landscape. Key partners for your success can be investors, distributors, local government authorities, marketing partner, or manufacturing partner, that helps to localise your products in China. This webinar will help you understand the different types of partnership models and how you can access to them.
Speakers
Yvonne Huang
Director of Strategic Development, Shenzhen Langhua Biotechnology Co., Ltd.
With a combined background in investment and industry, Yvonne has extensive experience in healthcare and finance. In 2015, she served as Co-Founder and Director of Financial Products at a company incubated within GTJA Investment Group, providing nearly £70 million in funding services to invested medical enterprises. She has been BD and Investment Directors in leading medical device companies, accumulating rich experiences in the investment + incubation + operation model, as well as early-stage incubation and investment in ophthalmology translational innovation products.
Cyndi Zhai, Founding Partner of HiMed Angle Fund Management
Cyndi holds the Chinese Institute of Certified Public Accountants (CICPA), International Technology Transfer Manager (RTTP) and rich experience in Business, Tax, Finance and Investment.
HiMed Angle Fund Management is a venture capital fund founded in 2015 and based in Shanghai China, dedicated to early-stage life science projects. The firm invests in early-stage life science ventures from Seed to Series A. HiMed also has accelerator programmes in China. In 2024, HiMed opened its office in UK, aiming to support more UK companies entering China market.
James Foster, CEO, Virax Biolabs
As Founder and CEO of Virax Biolabs (Nasdaq: VRAX) from the UK, James leads the development and global commercialisation strategy of innovative diagnostics focused on immune profiling for viral diseases. Over the past 12 years, James has built Virax into a cross-regional biotechnology platform with operations in the UK, US, and Asia—successfully navigating regulatory pathways, scientific validation, and public market entry.